Following a number of clinical trails, the national media has highlighted the evidence that Evusheld is effective for protecting clinically extremely vulnerable people from covid-19.
Find the stories below:
BMJ, 08 Nov 2022 - Covid-19: Evusheld protects the most vulnerable patients, analysis shows